ANXIETY AND DEPRESSION DURING COVID-19 IN INDIA
- Conditions
- B972||Coronavirus as the cause of diseases classified elsewhere
- Registration Number
- CTRI/2020/04/024784
- Lead Sponsor
- Dr Sameer Malhotra SELF SPONSORED NO CONFLICT OF INTEREST
- Brief Summary
**Aim:**
1.To understand the prevalence of symptoms of Depression and Anxiety in general population during COVID-19 in India 2.To understand correlation between COVID-19 related factors and mental health symptomology in the general population in India Hypothesis: There is likelihood of significant symptoms of depression and anxiety among general population in India during the current COVID-19 outbreak. Procedure: The participants would be selected with their informed consent. The objective of the study would be clearly written on Page 1 of the survey. The test would be administered electronically by all the participants individually only when consented to the study. The data collected will be kept strictly confidential and the identity of the participants will not be disclosed at any point of the research Measures: 1. Demographic Information Demographic variables included Gender, Age, Place of Stay, Marital Status, Highest Level ofEducation, current living arrangement (e.g. staying alone or with family) and Occupation. It further includesregular employment status and current employment status(e.g, Work from home, temporary leave, termination etc) 2. History of illness (Present or past) History of physical ailment specified (diabetes, hypertension, heart ailment or being on any steroid or any other chronic ailment) Previous history of H1N1/ Influenza like illness 3. COVID-19 Information This section includes time spent focusing on COVID related information, current stressors with respect to COVID-19 and coping mechanisms used. This further includesinformation on resources available to participants near their place of stay and information of any known diagnosed case of COVID-19. 4. Standardized Scales to be used Generalized Anxiety Disorder Scale (GAD-7); Patient Health Questionnaire (PHQ-9)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- All
- Target Recruitment
- 1000
Participants of the age of 18 years and above Participants residing in India Participants with minimum 10 years of education with basic knowledge of English.
Participants under the age of 18 years Participants residing outside of India Participants with previous history of any major psychiatric illness, psychiatric hospitalization or currently on any psychiatric medication.Â.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To understand the prevalence (magnitude) of depression and anxiety of general adult population during COVID-19 using Generalized Anxiety Disorder Scale (GAD-7) and Patient Health Questionnaire (PHQ-9). Rise in Anxiety and Depression will be noted. 1 month during the period of COVID-19 pandemic.
- Secondary Outcome Measures
Name Time Method Through the analysis of the results, it will help device psychological intervention/mental health programs geared towards general and specific symptoms and management of emotional needs can be provided to the general population during and post-crisis. 1 month during the period of COVID-19 pandemic.
Trial Locations
- Locations (1)
Max Super Speciality Hospital
🇮🇳South, DELHI, India
Max Super Speciality Hospital🇮🇳South, DELHI, IndiaSameer MalhotraPrincipal investigator9810022980sameer.malhotra@maxhealthcare.com